India Equity: Orchid_Pharma (#ORCHPHARMA) declares Quarterly Results. EPS = Rs -7.57 for quarter ended Jun 2021

0
428

Join the India Equity Telegram Group for analysis, updates and results

ORCHPHARMA has declared results for the period ended Jun 2021.

Quarterly Results

[s2If !current_user_can(access_s2member_level1)] Register and Login below to read result analysis [lwa][/s2If] [s2If current_user_can(access_s2member_level1)]

  • Sales for period ended Jun 2021 is Rs 92.0 cr compared to Rs 119.0 cr for period ended Jun 2020, a fall of 22.7%
  • Company reported negative operating profit of Rs -3.0 cr for period ended Jun 2021. For same period last year, operating profit was 19.0
  • The EPS for Jun 2021 was Rs -7.57 compared to Rs -6.06 for previous quarter ended Mar 2021 and Rs -5.55 for Jun 2020
  • The stock is trading at Rs 437 and a market cap of Rs 1782 cr

[/s2If]

Trading Chart


Further analysis and Full Company Research with investing scores is available here: ORCHPHARMA

Join BharatEquity Telegram Channel for updated India results, analysis and News
Join Our Twitter

This site uses Akismet to reduce spam. Learn how your comment data is processed.